An interim analysis of clinical trial results in the United Kingdom and Brazil showed that a COVID-19 vaccine candidate codeveloped by AstraZeneca and Oxford University had an average efficacy of 70% with no significant safety concerns.One dosing regimen was 90% efficacious when the vaccine, AZD1222, was given as a half dose, followed by a full dose at least 1 month apart. The other dosing
Websites focused on inhaler technique frequently overlook important preparation steps and device care/maintenance, according to results published in Respiratory Medicine.These findings emphasize the importance of…
Implementing the recent stronger standard for fine particulate pollution revealed that 131 million Americans breathe unhealthy, polluted air where they live, according to a press…
Patients in rheumatoid arthritis remission who tapered off conventional synthetic disease-modifying antirheumatic drugs had higher risks for flares, with two methods failing to reach non-inferiority…
Vonoprazan was noninferior to high-dose IV proton pump inhibitor therapy in preventing 30-day rebleeding among patients with high-risk peptic ulcer bleeding who had achieved endoscopic…
SAN DIEGO — Researchers have developed a new tool to assess malnutrition in children with end-stage kidney disease to help prevent protein-energy wasting, according…
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Alice T. Epitropoulos, MD, FACS, discusses Vevye, a cyclosporine solution that treats signs and…
In a 3-2 vote, the Federal Trade Commission passed a final rule that bans new noncompete agreements with all workers in for-profit organizations. For existing…
Less than optimal heart health at midlife was associated with a decline in the mental processing speed of Black women, but not white women, researchers…
ATLANTA — Adults genetically predisposed to high stress are more likely to have a heart attack during times of heightened stress, such as a major…
Find allergy and asthma news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.
